ICUCW SeaStar Medical Holding Corporation - Warrant
0.0154USD-0.65%Mkt Cap: —P/E: —6d ago
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers…
Industry Peers
Biotechnology$127.47BUSDP/E 29.3
$78.65BUSD
$76.14BUSDP/E 18.3
$51.48BUSDP/E 31.2
$48.23BUSDP/E 31.4
$41.82BUSDP/E 17.8
$40.32BUSD
$39.83BUSDP/E 62.6
$32.48BUSDP/E 29.9
$30.04BUSDP/E 37.9
$24.71BUSD
$23.13BUSD
$22.85BUSDP/E 14.4
$22.17BUSDP/E 28.4
$21.94BUSD
$21.10BUSDP/E 29.1
$14.65BUSDP/E 17.1
$14.62BUSDP/E 18.6
$14.44BUSDP/E 15.2
$13.70BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)1.71M USD
Gross Profit1.18M USD
Net Income (TTM)-12.15M USD
Revenue/Share0.48 USD
Last Price0.0154 USD
Fiscal Year End—
MR Quarter—
Employees18
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.013711% of range0.0298
52W High0.0298 USD
52W Low0.0137 USD
Profitability
Gross Margin95.71%
Oper. Margin-616.42%
EBITDA Margin0.00%
Profit Margin-984.60%
ROE-116.65%
ROA-85.82%
Growth
Revenue Growth82.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.60M USD
CapEx (TTM)—
FCF Margin-533.63%
FCF Yield—
Net Debt-6.83M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio1.89
Quick Ratio1.65
Book Value/Sh1.01 USD
Cash/Share1.58 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float4.36M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta-1.07
S&P 52W Chg15.78%
Avg Vol (30d)14.17K
Avg Vol (10d)—
Technical Indicators
RSI (14)49.2
MACD-0.0022
MACD Signal-0.0028
MACD Hist.+0.0005
BB Upper0.0205 USD
BB Middle0.0170 USD
BB Lower0.0135 USD
BB Width41.08%
ATR (14)0.0022 USD
Vol Ratio (20d)5.55x